Faculty who have authored publication Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia.
Name | Title | Department | Institution |
---|---|---|---|
Samantha M. Jaglowski MD, MPH | Professor | Medicine | Medical College of Wisconsin |